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Abstract
Background: There are several types of tobacco control interventions/policies which can change future smoking exposure.
The most basic intervention types are 1) smoking cessation interventions 2) preventing smoking initiation and 3)
implementation of a nationwide policy affecting quitters and starters simultaneously. The possibility for dynamic
quantification of such different interventions is key for comparing the timing and size of their effects.
Methods and Results: We developed a software tool, DYNAMO-HIA, which allows for a quantitative comparison of the
health impact of different policy scenarios. We illustrate the outcomes of the tool for the three typical types of tobacco
control interventions if these were applied in the Netherlands. The tool was used to model the effects of different types of
smoking interventions on future smoking prevalence and on health outcomes, comparing these three scenarios with the
business-as-usual scenario. The necessary data input was obtained from the DYNAMO-HIA database which was assembled
as part of this project. All smoking interventions will be effective in the long run. The population-wide strategy will be most
effective in both the short and long term. The smoking cessation scenario will be second-most effective in the short run,
though in the long run the smoking initiation scenario will become almost as effective. Interventions aimed at preventing
the initiation of smoking need a long time horizon to become manifest in terms of health effects. The outcomes strongly
depend on the groups targeted by the intervention.
Conclusion: We calculated how much more effective the population-wide strategy is, in both the short and long term,
compared to quit smoking interventions and measures aimed at preventing the initiation of smoking. By allowing a great
variety of user-specified choices, the DYNAMO-HIA tool is a powerful instrument by which the consequences of different
tobacco control policies and interventions can be assessed.
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Introduction
After half a century of tobacco control policy, a vast range of
interventions has been proposed, evaluated and implemented with
varying degrees of success, though none of these have turned out
to be fully effective in the worldwide eradication of tobacco
consumption as a deadly habit [1,2,3]. In the Netherlands overall
smoking prevalence is still high at 27% and has remained relatively
constant over the past decade. Among adolescents 21% declared
to be smoking in 2010 [4]. Policymakers are required to choose
which of the numerous interventions to implement, but lack
quantitative information on the long term impact of such
interventions on population health. Would it be more effective
to target smoking interventions to stimulate smokers to quit, or to
discourage adolescents from initiating smoking, or should policy
measures be targeted population-wide by advertisement restric-
tions, smoke-free public places or tobacco price adjustments? And
how will this affect the smoking distribution and population health
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in the short and long term? Existing Dutch tobacco control policies
and interventions currently include some in-school smoking
prevention interventions for those aged 10 to 12 and smoking
cessation interventions for adults. The latter mainly consist of
telephone help lines, intensive telephone coaching, and tailored
online quit smoking advice. Regarding population-wide tobacco
control policies the Netherlands has implemented advertising
restrictions, health warnings and smoke-free legislation, but there
is potential for even more stringent legislation like a further tax
increases, as currently the tax percentage of the retail price of
cigarettes is still below the officially recommended level [3].
Interventions differ in terms of their effectiveness and their
ability to reach different population groups. All vary in terms of
efforts and implementation costs [5]. Changing demographic
characteristics, competing morbidity as well as age-dependent
patterns of disease incidence, mortality and relative risks (RRs)
associated with smoking complicate the possibilities to quickly
oversee the consequences of tobacco control scenarios on future
population health, and hamper informed decision making.
We developed a software tool, DYNAMO-HIA, which allowed
us to make a quantitative comparison of the health impact of
different policy scenarios over time, by comparing the policy
scenario with the ‘‘business-as-usual’’ scenario, i.e. no change as
compared to the current situation. The tool has been described in
more detail elsewhere [6]. Here we will illustrate the capacities of
the DYNAMO-HIA model to estimate the long term health
impact of three typical types of tobacco control interventions if
these were applied in the Netherlands, alluding to Rose’s
distinction between high-risk vs. population wide approaches [7].
We concentrate on the following interventions: 1) smoking
cessation interventions in adult smokers 2) preventing smoking
initiation in adolescents and 3) implementation of a nationwide
intervention affecting quitters and starters simultaneously, by
adjusting the price of cigarettes through increased taxation. Using
these three scenarios, we demonstrate the possibilities to
dynamically quantify notions which are known intuitively. To
measure the impact on health we focus on the future prevalence of
smoking-related chronic diseases such as lung cancer, chronic
obstructive pulmonary disease (COPD) and ischemic heart disease
(IHD), as well as on mortality.
Methods
Description of DYNAMO-HIA
DYNAMO-HIA is a recently-developed Markov type, multi-
state simulation software. It was developed to allow researchers
and policy makers in the field of Health Impact Assessment (HIA)
to 1) quantify the development of risk factor exposure over time
and to 2) estimate the impact of these changes in risk factor
exposure on disease prevalence, mortality and on summary
measures of population health. DYNAMO-HIA is a dynamic tool
that synthesizes data according to the causal epidemiological
pathway, linking risk factor exposure through relative risks (RRs)
of incidence of associated diseases and death, to prevalence of
diseases, mortality and summary measures of population health,
and allowing to take into account relative risks by ‘‘time since
quitting smoking’’ and age, as well as competing risks. Following
the epidemiological causal chain implies that the model uses
relative risks by risk factor class, i.e. incidence in exposed risk
factor classes are a multiple of the incidence in the non-exposed. A
change in risk factor exposure due to the policy or intervention
thus changes disease incidence and in turn disease prevalence and
mortality. The effect of the risk factor change on mortality through
diseases not included in the model, i.e. other-cause mortality, is
taken into account by additionally using the relative risk on total,
i.e. all-cause, mortality. Other mortality is derived from total
mortality and disease specific mortality, assuming additive
mortality [8].
In order to isolate the effects of the intervention DYNAMO-
HIA always compares one or more intervention scenarios which
result in a modified risk factor prevalence and/or modified
transition rates, with the reference or business-as-usual scenario.
DYNAMO-HIA requires input such as 1) demographic data,
including population numbers, numbers of future newborns and
all-cause mortality, and 2) epidemiological information on
incidence, prevalence and mortality (IPM) for relevant diseases,
risk factor exposure, as well as relative risks linking exposure to
disease and to all-cause mortality, all by age and sex. The present
version of the DYNAMO-HIA software package, which is publicly
available at: www.dynamo-hia.eu, includes input data on risk
factor prevalence, relative risks, and IPM information for nine
diseases for a large set of EU member states. The diseases included
in the model are diabetes, ischemic heart disease, stroke, lung
cancer, oral cancer, esophageal cancer, colorectal cancer, breast
cancer and COPD. The risk factors include the body mass index
(BMI), alcohol and tobacco consumption. Time since quitting
smoking is taken into account by including prevalence and relative
risks in former smokers by time since quitting. The model provides
output on summary measures of population health such as life
expectancy with and without disease, mortality, survival as well as
disease and risk factor prevalence by age and sex. The effect of an
intervention or policy on future risk factor exposure and future
health is assessed by comparing one or more scenarios with a
specific intervention or policy change to a scenario without any
intervention, so business-as-usual. The effects of the intervention
or policy on the risk factor prevalence in the first year and/or on
transitions between risk factor states (i.e. smoking (re) start and quit
rates) are given by the user. The risk factor prevalence in future
years is an outcome of the model. The theoretical specifications of
the model have been described elsewhere [6].
Three smoking intervention scenarios and a reference
scenario
We evaluated the effects of three intervention scenarios, each
reflecting one of the three basic types of tobacco control: 1)
interventions to increase quitting, 2) interventions to reduce
smoking initiation and 3) policies reducing population-wide
smoking. Interventions to increase the quit rate among smokers
are usually targeted towards adults and include measures such as
counseling and personal or grouped pharmacological and/or
psychological therapy. Interventions to decrease or prevent
smoking initiation usually target adolescents and are often
school-based interventions. Nationwide policy measures for
population-wide smoking reduction, such as the use of tobacco
price taxation, affect quitting and starting simultaneously.
Each intervention scenario is characterized by a change in
smoking prevalence in the first year, i.e. just after the intervention
or policy, and/or by changed (re)start and quit rates, as compared
to the reference scenario. In addition, the proportion of the target
population that will effectively be reached by the intervention
characterizes the intervention scenario. We modeled both a
maximum scenario, which gives a better impression of the varying
effects over age and time for maximally effective interventions,
versus a more realistic scenario version. To quantify the order of
magnitude of the change in smoking prevalence and/or (re)start
and quit rates in the target population, we evaluated systematic
reviews/meta-analyses, and where necessary, primary articles of
intervention studies, based on a PubMed literature search.
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Reference scenario. The reference scenario starts from the
current prevalence of never, former and current smokers by age
and sex, and from current transition probabilities between the risk
factor states over the life course. The current prevalence e.g.
specifies what percentage of those presently 20 years old are never,
former or current smokers and the current transition rates, i.e.
(re)start and quit rates of smoking, specify how many of the
currently 20 years old never smokers will remain never smokers
when they are 21, 22 etc. years old, and how many start smoking
when they are 21, 22 etc. years old. The current prevalence and
transition rates relate to the business-as-usual situation, that is, a
situation with smoking control measures that are already in place,
but without the specific intervention. Dutch baseline prevalence of
smokers, former smokers and never smokers and smoking (re)start
and quit rates used here are included as supporting information
(Appendix S1). The DYNAMO-HIA database provided
information on smoking prevalence, i.e. the percentage of
current smokers, former smokers and never smokers for ages 16
and over, based on the POLS study [9] (for further information
please refer to the data documentation section of the DYNAMO-
HIA project website: www.dynamo-hia.eu). Smoking prevalence,
i.e. the percentage of smokers and the percentage of non-smokers
for ages 10 to 15 was derived from Stivoro’s Jeugdmonitor (Youth
monitor) [10], which is the Dutch center for expertise on tobacco
prevention. The age- and sex specific start, quit and restart rates
for ages 16 years and over were also based on information
available through Stivoro [11]. For ages up to age 16, ‘‘net’’
smoking initiation rates were estimated using a standard life table
of a cohort of non-smokers, whose number decreases with age
because persons take up smoking. Using net initiation rates means
that flows into the non-smoking state are not explicitly modeled,
e.g. if 100 adolescents start smoking and 4 quit, the net uptake is
96. Also restart rates are not separately modeled at these ages.
Relative risks from smoking categories to diseases and all-cause
mortality used in this analysis as well as an overview of the age-
specific disease prevalence at baseline are also included as
supporting information (Appendix S2).
The ‘‘smoking cessation intervention’’: change in quit
behavior. For the first scenario, the ‘‘smoking cessation
intervention’’, we chose an odds ratio (OR) of 2.0 reflecting that
the ORs quantifying the effects of interventions on cessation rates
varied from 1.4 to 2.2 among persons aged 18 years and over to
which these interventions are usually targeted [12,13,14,15,16].
This resulted in post-intervention cessation rates about twice as
large as in the reference scenario. These were assumed to remain
constant over the entire projection period.
The ‘‘smoking initiation intervention’’: change in start
behavior. For the second scenario, the ‘‘smoking initiation
intervention’’, we assumed a 50% decrease in the smoking
initiation rate for those at school ages 10–18 in the maximum
scenario, and a 20% reduction in the realistic scenario version,
reflecting that the literature showed mixed results varying from no
effects to a significant reduction in start rates [17,18,19]. These
post-intervention initiation rates were assumed to remain constant
over the entire projection period.
The ‘‘population-wide smoking control policy’’: change in
(re)start and quit behavior. For the third scenario, the
‘‘population-wide smoking control policy’’, we almost doubled the
price of tobacco products. That is, we chose to use a 95% increase in
the price of tobacco in the maximum scenario, which reflects the
price adjustment if the Netherlands was to increase the price of
tobacco to match the price of tobacco in Ireland, which currently
has the highest tobacco price in the EU [20]. In the realistic scenario
version, we assumed a smaller price increase of 20%.
The effect of the price increase on smoking is based on a price
elasticity, which measures the average proportional reduction in
demand when the price of a commodity increases. We used a price
elasticity of smoking prevalence of 20.4 for persons aged 21 and
over and of 20.7 for persons up to age 20, who usually show
greater responsiveness [21]. Hence, we assumed that a 95%
increase in price in the maximum scenario leads to a 66.5% (i.e.
0.7*95%) reduction in smoking prevalence among persons below
age 21, and for persons aged 21 and over to a 38% (i.e. 0.4*95%)
reduction. In the realistic scenario, we used 14% and 8%,
respectively. Given that most smokers start smoking before age 21,
we further assumed that for adults the decrease in prevalence of
smokers originates from an increase of former smokers, i.e. higher
quit rates and not from lower start rates, and that the adults who
quit smoking do so immediately after the price increase, that is, we
assumed that they will not show any delayed change in smoking
status in the years after the price change. Therefore, we left their
future transition probabilities unchanged, except for the restart
rates. Restart rates were adjusted by the same percentage as the
start rates, based on the assumption that if persons quit because of
the higher price, this high price will also reduce their likelihood to
restart smoking in the future. These new start rates were assumed
to be valid during the whole projection period. For persons up to
the age of 20 we assumed that decreases in the prevalence of
smoking originate from an increase in never-smokers, i.e., fewer
people starting to smoke. We also assumed that children in future
years, upon reaching the ages where they would take up smoking,
would have the same smoking prevalence as their peers after the
intervention. Given the higher price they are assumed to be less
likely to start smoking as compared to the situation with the lower
price. To ensure that the future prevalence of smoking among
adolescents remained at this post-intervention level, starting rates
were obtained that are consistent with the new, lower smoking
prevalence, also using the above life table approach.
Reach of the interventions. In the maximum scenarios, we
assumed that 100% of the target population will be reached by the
interventions. However, given that the size of the population that
will be reached by an intervention is likely to be smaller, and is likely
to differ by type of intervention, we assumed a lower reach for the
smoking cessation intervention and the smoking initiation
intervention in the realistic scenario versions. Considering that
approximately 40% of smokers are willing to give up smoking in the
coming year [22], and assuming that, due to possible supply-side
constraints of such interventions, only about 50% of those wanting
to quit will actually participate in the interventions, we used a reach
of 20%. In the realistic version of the smoking initiation intervention
we assumed that, while virtually all adolescents are at risk of taking
up smoking, only half of them will be reached by these school
interventions. For the population-wide smoking control policy, we
assume that both in the maximum and realistic scenarios virtually
the whole population will face the higher price, and hence made no
distinction between the reach of the maximum and realistic scenario
versions. The assumptions for the maximum and realistic scenario
versions are summarized in Table 1.
We compared the changing patterns of smoking prevalence and
health impact of each of these scenarios with the reference
scenario over time, using DYNAMO-HIA.
Results
Effect of interventions on future prevalence of current,
former and never smokers
The smoking cessation intervention will cause an initially strong
decrease in the prevalence of current smokers, mirrored by an
Comparison of Tobacco Control Scenarios
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increase in the prevalence of former smokers as compared to the
reference scenario (Figure 1a–c). By definition the prevalence of never
smokers is not affected by this intervention. In the first years after the
intervention, the prevalence of current smokers decreases more
quickly than in the reference scenario, yielding an increasing
reduction in the prevalence of current smokers due to the
intervention. After 15 years (year 2025), this reduction in the
prevalence of current and former smokers becomes stable. In the
smoking cessation scenario the prevalence of current smokers is
estimated to fall to 14% in 2035, versus 20% in the reference scenario.
The smoking initiation intervention also causes a decrease in the
prevalence of current smokers as compared to the reference
scenario, but it is smaller than in the smoking cessation scenario.
In the short-term this decrease is mirrored by a similar increase in
the prevalence of never smokers and no change in the prevalence
of former smokers (Figure 1a–c). The overall prevalence of current
smokers decreases steadily and more rapidly than in the reference
scenario, causing a major change in the age-distribution of current
smokers over time (Figure 2a–f). Initially the reduction in smoking
prevalence rates due to the intervention only occurs at younger
ages. Increased projection time allows the effects to expand to
older ages as the adolescents affected by the intervention reach
adulthood and in the end old age.
Compared to the reference scenario, the population-wide
smoking control policy causes an immediate decrease in the
prevalence of current smokers, reflecting that the price increase is
assumed to affect behavior virtually immediately. Evidently, this
decrease is initially accompanied by a higher prevalence of former
and never smokers, as in the model adults were assumed to quit
and adolescents not to take up smoking in response to the price
increase. Further, in the longer run the prevalence of former
smokers becomes lower than in the reference scenario (Figure 1a–
c), reflecting that less smoking initiation reduces smoking
prevalence and in turn reduces former smoking prevalence. The
population-wide smoking control policy affects the prevalence of
current smokers in all age groups. Initially an increase of former
smokers is seen at all ages, reflecting the massive number of
individuals quitting due to the doubling of the price. With
increasing projection time the prevalence of former smokers drops
below their prevalence in the reference scenario. This effect starts
at the youngest ages and with time expands to older ages
(Figure 2a–f). This pattern is the net effect of two opposing effects.
Firstly, an immediate increase in prevalence of former smokers
due to the price increase, and secondly, a delayed opposite effect
reflecting that less smoking initiation reduces current smoking
prevalence and in turn reduces the prevalence of former smokers.
This latter effect expands gradually to older ages.
The set of realistic scenario versions for each of the three types
of interventions/policy models smaller effects on smoking
exposure. This either reflects less dramatic interventions (e.g.
smaller price increase), smaller effects of the interventions on the
persons who participate (e.g. 20% reduction in start rates as
compared to 50%) and/or a smaller percentage of the target
population that participates (reach). This revealed similar patterns
of smoking prevalence, though being less pronounced (Figures
S1a–c and S2a–f).
Effect of interventions on future disease prevalence
Table 2 shows the effects of the maximum scenarios on the
point prevalence of smoking-related diseases such as lung cancer,
COPD, IHD as well as on the prevalence of those with at least one
disease, i.e. diabetes, ischemic heart disease, stroke, lung cancer,
oral cancer, esophageal cancer, colorectal cancer, breast cancer
and COPD for the years 2035 and 2060. On the left we display the
absolute baseline level and percentage and the difference due to
the intervention in the prevalence of the respective diseases after
25 years, as compared to the reference. On the right we show
results after 50 years, i.e. for the year 2060. These are two
snapshots in time showing how the effects build up over 25 and 50
years, respectively. Figures showing the evolution over time in
more detail are available from the authors on request.
The population-wide smoking control policy causes the largest
reduction of the prevalence of lung cancer, COPD, IHD and of
persons with at least one disease. By 2035 this intervention prevents
about 67,000 COPD cases, 5,000 lung cancer cases, 54,000 IHD
cases and about 93,000 cases of persons with at least one disease.
The smoking cessation intervention takes a middle position on the
prevalence reduction for the listed diseases. The smoking initiation
intervention builds up much slower since it will only exert its effects
when those prevented from smoking would have otherwise become
ill. Thus, even in 25 and 50 years time, the effects on disease
prevalence are substantially smaller than in the other two scenarios.
The effects of the realistic scenarios on disease prevalence in
2035 and 2060 were similar in shape, but evidently smaller than in
Table 1. Interventions used in this paper, maximum vs. realistic scenarios versions.
Scenario Maximum scenario versions+
Realistic scenario
versions++
Impact Reach Impact Reach
1. ‘‘Smoking Cessation Intervention’’
Targeting adult smokers (18 yrs and over)
to quit through quit intervention
OR: 2.00 on quit rate 100% of smokers OR: 2.00 on quit rate 20% (40% smokers
want to quit * 50%
of those are reached)
2. ‘‘Smoking Initiation Intervention’’
Targeting adolescents (10–18 yrs) not to
start through an in-school intervention
50% decrease of start rate 100% of non-
smokers
20% decrease of start rate 50% (100% at risk to
start, 50% reached)
3. ‘‘Population-wide Smoking Control Policy’’
Targeting entire population through a price
increase (95% in max. and 20% realistic scenario)
Ages up to 20: increase never
smokers by 66.5% and reduction
start rates. Ages 21 and above:
increase former smokers by 38%.
Decrease of restart rate to 30% of
reference.
100% of entire
population
Ages up to 20: increase never
smokers 14% and reduction
start rates. Ages 21 and above:
increase former smokers 8%.
Decrease of restart rate to 80%
of reference.
100% of entire
population
+See figures 1a–c, 2a–f and 3, table 2 for results.
++See figures S1a–c, S2a–f and S3, table S1 for results.
doi:10.1371/journal.pone.0032363.t001
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the maximum version. The exact results for the realistic scenario
versions can be seen in Table S1.
Effect of interventions on future deaths/lives saved
Figure 3 shows the difference in the excess number of deaths
from all causes by calendar year due to each intervention, the
baseline number of deaths being 125,650. The population-wide
smoking control policy scenario prevents the most deaths. The
effects of the interventions on the excess number of deaths as
compared to the reference scenario in the population-wide
smoking control policy and the smoking cessation intervention
both first show an increase, followed by a reduction. This reflects
two opposite effects. Firstly, fewer deaths occur, due to the lower
prevalence of smoking, reducing the prevalence of smoking-related
Figure 1. Smoking prevalence over time; Effects of each scenario in the Netherlands (maximum version, panels a–c).
doi:10.1371/journal.pone.0032363.g001
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Figure 2. Smoking prevalence by age; Effects of each scenario in the Netherlands (maximum version, panels a–f).
doi:10.1371/journal.pone.0032363.g002
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diseases. Secondly, more deaths occur in the longer run because
the intervention keeps persons alive longer, yielding an on average
older population. Simultaneously, this also translates into an
increase in healthy life expectancy: HLE for men (women) for
maximum scenarios in 2010 at baseline: 68.26 (71.45) years; in
2035 without intervention: 69.70 (71.90), with smoking cessation
intervention: 70.25 (72.30), with smoking initiation intervention:
69.71 (71.91) and with population-wide policy: 70.79 (72.73). HLE
for men (women) in 2060 without intervention: 70.22 (72.11), with
smoking cessation intervention: 70.92 (72.67), with smoking
initiation intervention: 70.41 (72.25) and with population-wide
policy: 71.64 (73.32). Similar mortality patterns can be observed
for the realistic scenario versions, displayed in Figure S3.
Discussion
Main findings
The comparison of the three types of interventions shows that
the population-wide smoking control policy causes an instant
exposure improvement, while also resulting in the largest decrease
in the prevalence of current smokers, in disease prevalence and in
the number of deaths. The smoking cessation scenario results in
the next largest decrease. The reduction of smoking prevalence
under the smoking initiation scenario builds up over time and will
be highly effective in the future, while being least effective in the
short run. Of course, the potential effects of the population-wide
policy are the largest as this scenario, by definition, reaches the
entire population, whereas the other scenarios only affect quitters
or those who might take up smoking. However, given the goal of
smoking eradication, it is crucial to keep the long-run benefits of
the initiation intervention in mind, since here potential future
smokers are kept from ever even taking up the habit.
The fact that the population-wide policy yields larger effects
may be seen as support for Rose’s claim that population strategies
are often the most effective, in contrast to the cessation
intervention which could be classified as a ‘‘high risk approach’’
according to his classification [7]. However, the gains of the
population-wide scenario presented here can only be realized if
sufficient smoking cessation services are available that enable
smokers to successfully quit smoking.
The effects of the future reduction in smoking prevalence have
implications in terms of health. All three intervention scenarios
resulted in fewer excess prevalence cases of smoking-related
diseases such as COPD, lung cancer and ischemic heart disease
and fewer deaths after the intervention, though the level and
timing of the effects differed. The population-wide smoking
control policy showed the largest reduction in disease prevalence,
followed by the smoking cessation scenario. On the other hand, we
see virtually no effect of the initiation scenario until the end of the
projection interval, because the group that does not take up
smoking due to the intervention, will not yet have had the chance
to develop the major smoking-related diseases during most of the
period, as it takes years until these adolescents enter the age ranges
where incidence of these chronic diseases is substantial. In the long
run the health effects of the smoking initiation scenario start to
build up.
The population-wide smoking control policy also reaches the
largest reduction in deaths, again followed by the cessation
scenario. The effect of the population-wide smoking control policy
and cessation intervention on the number of deaths first rises, then
falls and in the end even completely disappears. With time the
reduction in deaths due to the lower prevalence of smoking-related
diseases, such as COPD, lung cancer and IHD is increasingly
nullified because the intervention keeps persons alive longer,
yielding an on average older population with a higher prevalence
of non-smoking related diseases such as diabetes (data not shown)
and dampening the reductions of prevalence of smoking-related
diseases. This goes in line with estimates of (healthy) life
expectancy, also calculated by the DYNAMO tool, which increase
over the projection period, and where the improvement is bigger
between 2010 and 2035 than between 2035 and 2060.
The differences in timing can be explained by the fact that these
different types of interventions/policies target different exposure
groups (current smokers vs. never/non smokers vs. entire
Table 2. Effects of scenarios on point prevalence of diseases in the Netherlands (maximum version).
Absolute Level and Reduction in Disease Prevalence as Compared to Reference Scenario
2010–2035 2010–2060
Lung Cancer COPD IHD
at least one
disease
Lung
Cancer COPD IHD
at least one
disease
Absolute Baseline Prevalence 2010 12,863 211,798 508,596 1,483,769 12,863 211,798 508,596 1,483,769
change Scenario 1 (Cessation) 2,957 36,087 23,967 47,712 2,753 39,299 23,684 32,625
change Scenario 2 (Initiation) 3 0 94 118 534 6,167 10,880 17,465
change Scenario 3 (Population-Wide Policy) 5,044 66,952 54,071 92,796 5,006 72,550 63,161 79,467
Percentage and Reduction in Disease Prevalence as Compared to Reference Scenario in Percentage Points
2010–2035 2010–2060
Lung Cancer COPD IHD
at least one
disease
Lung
Cancer COPD IHD
at least one
disease
Baseline Prevalence 2010 in Percent 0.079 1.305 3.130 9.131 0.079 1.305 3.130 9.131
change Scenario 1 (Cessation) 0.018 0.219 0.153 0.314 0.018 0.260 0.179 0.287
change Scenario 2 (Initiation) 0.000 0.000 0.001 0.001 0.003 0.040 0.072 0.118
change Scenario 3 (Population-Wide Policy) 0.030 0.406 0.345 0.620 0.033 0.478 0.453 0.650
*out of: diabetes, ischemic heart disease, stroke, lung cancer, oral cancer, esophageal cancer, colorectal cancer, breast cancer, COPD.
doi:10.1371/journal.pone.0032363.t002
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population), and hence different age groups. For example, since
the vast majority of smokers starts smoking before adulthood,
interventions preventing persons from taking up the habit mainly
target and affect these younger age groups. Cessation interven-
tions, on the other hand, will mainly affect the adult population.
Nationwide policy measures impacting population-wide smoking
behavior such as a tax on tobacco affect both the young and the
old. Age strongly affects the risks of the onset of chronic diseases,
both associated and unassociated with smoking, and of death.
Smoking-related diseases, such as COPD, lung cancer or IHD
only start taking a substantial toll in adulthood and early old age,
and within the smoking related diseases, the timing of the effects
differs, partly because of variation in the incidence rates by age.
Additionally, differences in timing can be explained by the effects
of the interventions on mortality and hence on ‘‘surplus’’ aging
caused by the intervention.
The dynamic modeling tool DYNAMO-HIA, with its ability to
quantify the effects of interventions or policies on future risk factor
prevalence and in turn on population health is a powerful
instrument when the consequences of different tobacco control
policies and interventions are to be assessed. Our findings not only
show the different general patterns which interventions can
produce but also illustrate how important it is that participation,
i.e. the reach of an intervention, is as high as possible. Only then
will interventions produce the desired effects on the population
level. Such differences are illustrated well by our comparison of the
maximum and the realistic scenario versions for the cessation and
initiation interventions. This goes in line with the findings of other
simulation models. Using the SIMSMOKE model it was shown
that there is only a visible population effect of individual
interventions if as many smokers as possible attempt to quit and
as many of them also make use of the array of available quitting
support tools [23,24]. The RIVM Chronic Disease Model [25]
showed comparable projections of the effects of various quit
interventions on smoking prevalence in future years.
The present study modeled each intervention one by one. A
combination of several interventions and policies affecting
different target groups and covering different time horizons will
yield better tobacco control outcomes than the implementation of
just one intervention quantified in this study. However, in the
situation of more interventions the effect of one intervention will
depend on the effect of the second intervention, and vise versa. For
Figure 3. Difference in the number of deaths; Effects of each scenario in the Netherlands (maximum version).
doi:10.1371/journal.pone.0032363.g003
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instance, a smoking initiation intervention that is successful in
preventing adolescents from taking up smoking will reduce the
potential effects of a smoking cessation intervention among adults.
On the other hand, the population-wide intervention might be
more effective if those who are motivated to quit because of a price
increase are reached by smoking cessation interventions. These
interdependencies depend on the effectiveness and reach of the
interventions involved, as well as on the demographic and
epidemiological context. Given our purpose to disentangle and
illustrate the effects of three types of interventions, we did not
model combinations of intervention types.
Strengths and limitations
Some limitations of our analyses must be considered. While we
were aiming at a realistic model, a model always remains only a
simplified version of reality, here being a demonstration of stylized
scenarios. Much more work can still be put into the development
of actual and more elaborate scenarios. This is a simulation
analysis synthesizing existing data and evidence on disease
epidemiology, smoking exposure, effects of smoking exposure on
diseases and effects of smoking interventions on smoking exposure,
all by age and sex. DYNAMO-HIA compares the effects of
interventions/policies, i.e. it quantifies a reference scenario and
one or more intervention scenarios with a modified risk factor
exposure. The goal is not to project future population health as
such. For projecting future population health, accurate informa-
tion on incidence, prevalence and excess mortality data (IPM) of
the diseases included in the model are needed, while in reality
those data are embedded with uncertainty. This is partly because
of the presence of past trends which are not exactly known. For the
DYNAMO-HIA database it was decided to include trend-free
IPM data partly estimated using the DisModII software [26]. Such
trend-free data are used as a neutral option, because of the lack of
reliable information on trends. In view of the intended use of
DYNAMO-HIA, i.e. comparing scenarios, this choice is not very
significant as the same disease data are used both in the
intervention and reference scenario(s). Therefore, we do not
expect that this unavoidable compromise has an important effect
on the outcomes of our study.
Additionally, smoking prevalence and quit and (re)start rates
may be biased. Classifications of smoking exposure differ between
adolescents and the adult population, as do the data sources.
While for older ages non-smokers in the POLS study [9] were
further distinguished into former and never smokers, below age 16
in the ‘‘Youth monitor’’ [10], a distinction was only made between
non-smokers and smokers. A distinction of non-smokers into never
and former smokers at these ages is less meaningful, as these
adolescents will have smoked for only a short time anyway. Given
that prevalence data of smokers from different sources did not
indicate important inconsistencies, we do not expect that this has
biased the results. Further, quit and (re)start rates at younger ages
might be biased because at these ages flows into the non-smoking
state due to quitting were not explicitly modeled, nor were restart
rates. This yields an underestimation of the restart rates, but at the
same time also an underestimation of the quit rates which have an
opposite effect. Since the overall effect on the smoking prevalence
was consistent, we do not expect bias. The only issue is that when
changing the start rates in the ‘‘stop initiation scenario’’, the effect
may be slightly underestimated given that we used ‘‘net’’ start
rates. However, given that the higher start rates would have been
nullified by quit rates, we again expect no bias.
A second limitation relates to the translation of the effects of
interventions, as reported in the literature, into parameters of a
dynamic tool such as DYNAMO-HIA. For example, if interven-
tion studies report a reduction in the prevalence of smokers,
additional assumptions are needed about the origin of the
reduction: less initiation of smoking, increasing the prevalence of
never smokers vs. more quitting, increasing the prevalence of
former smokers. This translation was needed for the population-
wide smoking control policy. We made our choices explicit in the
paper. Assuming that most persons start smoking up to the age of
20, it is around this age when most uncertainty exists on whether
the reduction in smokers reflects less starting or more quitting.
Given that future health outcomes do not differ between former
and never smokers at these ages, we do not expect that this
affected our estimates. For older ages, mainly the expected effect of
the price increase on restart rates is embedded with uncertainty.
We expected that a price increase would also reduce the likelihood
that future former smokers take up smoking again, and assumed a
similar decrease in restart rates as in initial start rates. But other
quantifications of the effect on restart rates may be equally
defendable, and might yield different changes in future smoking
exposure and health. At the most extreme, assuming no change in
the restart rates would imply that the effect of this intervention on
smoking prevalence at adult and older ages would be virtually
absent during part of the projection period. While we do not
consider this a plausible scenario, it indicates that future
intervention studies should also evaluate the long-term effects on
future smoking behavior.
A third limitation of our study is that the comparisons of the size
of the effects partly depend on the exact quantification of each
intervention scenario. Given that evidence from current evaluation
studies is insufficient to set all the parameters in DYNAMO-HIA
or any other modeling tool with certainty, this cannot be avoided.
Next to a set of maximum scenarios we presented a set of realistic
scenario versions, which indicated that the general patterns
remained unchanged, only showing the lesser effects due to
smaller effect size and reach. Due to the model’s linear behavior all
specific interventions or smoking control policies with effectiveness
and reach specifications in-between these two versions will
produce results between the realistic and maximum variant.
The research presented here shows the general patterns of three
types of smoking interventions and illustrates the general use of
DYNAMO-HIA. For each of the three types of interventions a
wide range of smoking control or prevention services with varying
effectiveness and reach can be chosen. The effect of each specific
intervention will depend on its exact specifications and the current
risk factor exposure and demographic and epidemiological
context, which may differ from the Dutch situation. In particular,
in populations with a different smoking pattern, reflecting a
different stage in the smoking epidemic and/or a different mix of
smoking control policies, the room for gains that can potentially be
realized by different types of interventions may differ. DYNAMO-
HIA can be used to quantify these effects as it easily allows for
taking such factors into account.
The key strength of our study relates to using a dynamic
multistate model that distinguishes separate smoking states in
order to model the effects of the different interventions/policies.
Smoking affects a large range of diseases, each to a different
extent and the RRs associated with smoking also depend on age
and sex. Further, the different smoking-related diseases have
different epidemiological patterns (time of onset, mortality). The
health effects of different types of interventions depend on the
effects of the intervention on future smoking exposure at different
ages. Future smoking exposure, in turn, does not only depend on
prevalence at baseline, and (re)start and quit rates, but also on
selective mortality, as smoking is strongly associated with
mortality. Using DYNAMO-HIA allowed us to assess how an
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intervention affects smoking exposure in future years and in
different age groups, taking into account selective mortality, and to
substitute morbidity and mortality in the extra years persons are
alive because of the lower mortality due to the intervention. Other
models like SIMSMOKE [24] use the Potential Impact Fraction
(PIF) to model the effects of interventions on transitions, and hence
do not contain selective mortality.
Also, DYNAMO-HIA allowed us to take into account the effect
of smoking on various diseases, each having different excess risks,
which vary by age. The effect of smoking exposure on death was
accounted for through the effect of smoking on incidence of the
nine included diseases and through the RR of total mortality,
which allows DYNAMO-HIA to take into account the effect of
smoking on mortality through diseases not included in the model.
Technical advantages of our software also include the fact that it
requires relatively modest data input resulting in rich model
output, while being freely accessible through a website.
Conclusion
The DYNAMO-HIA model showed that all smoking interven-
tions will be effective in the long run, the population-wide strategy
being most effective in both the short and long term. The quit
smoking scenario evidently will be second-most effective in the
short run, though in the long run the smoking initiation scenario
will be almost as effective as the smoking cessation scenario. Even
if interventions aimed at preventing the initiation of smoking take
a long time to become manifest in terms of health effects, they
need to be part of tobacco control measures as they keep in check
the numbers of new smokers. A combination of interventions and
policies with different time horizons reinforcing each other would
be most optimal on the way to smoking eradication.
The dynamic modeling tool DYNAMO-HIA, with its ability to
quantify information on the long term impact of interventions on
population health, is a powerful instrument when the consequenc-
es of different tobacco control policies and interventions are to be
assessed. We can directly compare the differences in the timing as
well as in the relative sizes of the effects of the scenarios.
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